Back to Search
Start Over
Prevalence of immune-related adverse events and anti-tumor efficacy in advanced/metastatic urothelial carcinoma following immune-checkpoint inhibitor treatment
- Source :
- Clinical and Translational Oncology.
- Publication Year :
- 2023
- Publisher :
- Springer Science and Business Media LLC, 2023.
- Subjects :
- Cancer Research
Oncology
General Medicine
Subjects
Details
- ISSN :
- 16993055
- Database :
- OpenAIRE
- Journal :
- Clinical and Translational Oncology
- Accession number :
- edsair.doi...........c72b4f69ee48df23fb3a6c4a072387d3
- Full Text :
- https://doi.org/10.1007/s12094-023-03213-6